Evaluation of Response to Biosimilar Erythropoietin Alfa Therapy in Anemic Patients With Myelodysplastic Syndrome

Clinical trial NCT06764511 · RECRUITING

Trial details

NCT number: NCT06764511
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Status: RECRUITING
Study type: OBSERVATIONAL

Myelodysplastic Syndromes (MDS)

Start date: 2024-08-30
Primary completion: 2025-04-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.